NYSE:CI - CIGNA Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $207.78 -3.41 (-1.61 %) (As of 11/20/2018 04:00 PM ET)Previous Close$211.19Today's Range$207.24 - $211.8352-Week Range$163.02 - $227.13Volume1.80 million shsAverage Volume2.35 million shsMarket Capitalization$52.05 billionP/E Ratio19.88Dividend Yield0.02%Beta0.58 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers. This segment also provides Medicare Advantage and Medicare Part D plans to seniors, and Medicaid plans. The Global Supplemental Benefits segment offers supplemental health, life, and accident insurance products. The Group Disability and Life segment provides group long-term and short-term disability, group life, accident, and specialty insurance products and related services. The Other Operations segment offers corporate-owned life insurance products that are permanent insurance contracts sold to corporations to provide coverage; and run-off settlement annuity contracts. The company distributes its products and services through insurance brokers and insurance consultants; and directly to employers, unions and other groups, or individuals, as well as through direct response television and the Internet. Cigna Corporation was founded in 1792 and is headquartered in Bloomfield, Connecticut. Receive CI News and Ratings via Email Sign-up to receive the latest news and ratings for CI and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Hospital & medical service plans Sub-IndustryManaged Health Care SectorFinance Current SymbolNYSE:CI Previous Symbol CUSIP12550910 Webwww.cigna.com Phone860-226-6000 Debt Debt-to-Equity Ratio1.61 Current Ratio0.98 Quick Ratio0.98 Price-To-Earnings Trailing P/E Ratio19.88 Forward P/E Ratio14.48 P/E Growth1.21 Sales & Book Value Annual Sales$41.62 billion Price / Sales1.22 Cash Flow$12.7551 per share Price / Cash16.29 Book Value$55.71 per share Price / Book3.73 Profitability EPS (Most Recent Fiscal Year)$10.46 Net Income$2.24 billion Net Margins6.15% Return on Equity23.31% Return on Assets5.01% Miscellaneous Employees46,000 Outstanding Shares243,530,000Market Cap$52.05 billion OptionableOptionable CIGNA (NYSE:CI) Frequently Asked Questions What is CIGNA's stock symbol? CIGNA trades on the New York Stock Exchange (NYSE) under the ticker symbol "CI." How often does CIGNA pay dividends? What is the dividend yield for CIGNA? CIGNA declared a quarterly dividend on Wednesday, February 28th. Investors of record on Monday, March 12th will be given a dividend of $0.04 per share on Tuesday, April 10th. This represents a $0.16 annualized dividend and a yield of 0.08%. The ex-dividend date of this dividend is Friday, March 9th. View CIGNA's Dividend History. How will CIGNA's stock buyback program work? CIGNA announced that its Board of Directors has authorized a share buyback program on Sunday, June 4th 2017, which permits the company to buyback $3,700,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to reacquire up to 9.8% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's leadership believes its shares are undervalued. How were CIGNA's earnings last quarter? CIGNA Co. (NYSE:CI) announced its quarterly earnings data on Thursday, November, 1st. The health services provider reported $3.84 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $3.45 by $0.39. The health services provider had revenue of $11.45 billion for the quarter, compared to the consensus estimate of $11.19 billion. CIGNA had a net margin of 6.15% and a return on equity of 23.31%. CIGNA's quarterly revenue was up 10.3% on a year-over-year basis. During the same period in the previous year, the business earned $2.83 earnings per share. View CIGNA's Earnings History. When is CIGNA's next earnings date? CIGNA is scheduled to release their next quarterly earnings announcement on Thursday, February 7th 2019. View Earnings Estimates for CIGNA. What guidance has CIGNA issued on next quarter's earnings? CIGNA updated its FY 2018 earnings guidance on Thursday, November, 1st. The company provided earnings per share guidance of $14.20-14.40 for the period, compared to the Thomson Reuters consensus estimate of $13.84. The company issued revenue guidance of $45.153-45.153 billion, compared to the consensus revenue estimate of $45.18 billion. What price target have analysts set for CI? 13 brokerages have issued 12-month target prices for CIGNA's stock. Their forecasts range from $194.00 to $260.00. On average, they anticipate CIGNA's stock price to reach $235.5385 in the next year. This suggests a possible upside of 13.2% from the stock's current price. View Analyst Price Targets for CIGNA. What is the consensus analysts' recommendation for CIGNA? 13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CIGNA in the last year. There are currently 2 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CIGNA. What are Wall Street analysts saying about CIGNA stock? Here are some recent quotes from research analysts about CIGNA stock: 1. According to Zacks Investment Research, "Cigna’s earnings per share of $3.84 beat the Zacks Consensus Estimate by 11.3% and increased 36% year over year. Strong performance across the company’s Global Health Care, Global Supplemental Benefits and Group Disability and Life businesses aided earnings. Shares of Cigna have outperformed its industry's growth in a year's time. The company is on track to buy Express Scripts, which should raise its rank in the health insurance industry and lead to long-term growth. The company has received approval for the merger from the Department of Justice. A robust Global Supplemental business, growing Government business, increasing membership, and strong capital position are the other positives. Strong 2018 outlook reflects business strength. However, increase in leverage, rise in operating expenses and suspension of share buyback are concerns." (11/12/2018) 2. Cantor Fitzgerald analysts commented, ". We initiate coverage of Overweight rating and a 12-month price target of $245. Cigna is a large-cap health insurance company with a focus on self-insured employers. Segment accounted for 80% of operating revenue and 77% of adjusted operating income. The company also operates supplemental benefits and group disability and life businesses. the company announced the acquisition of Express Scripts (ESRX – Not Covered), a large pharmacy benefit manager (PBM). We believe the transaction, which should close by year-end 2018, is a logical fit, both strategically and financially, with natural synergies." (9/26/2018) Has CIGNA been receiving favorable news coverage? News stories about CI stock have trended negative this week, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. CIGNA earned a media sentiment score of -2.4 on InfoTrie's scale. They also assigned headlines about the health services provider a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future. Who are some of CIGNA's key competitors? Some companies that are related to CIGNA include Anthem (ANTM), Aetna (AET), Humana (HUM), Centene (CNC), WellCare Health Plans (WCG), Molina Healthcare (MOH), Trupanion (TRUP) and Advanzeon Solutions (CHCR). Who are CIGNA's key executives? CIGNA's management team includes the folowing people: Mr. David Michael Cordani, Pres, CEO & Director (Age 53)Mr. Eric Paul Palmer, Exec. VP & CFO (Age 41)Ms. Nicole Susan Jones, Exec. VP & Gen. Counsel (Age 47)Mr. Jason D. Sadler, Pres of International Markets (Age 49)Ms. Mary Terese Agoglia Hoeltzel CPA, VP & Chief Accounting Officer Who are CIGNA's major shareholders? CIGNA's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (6.93%), FMR LLC (3.68%), Dodge & Cox (3.65%), Capital World Investors (2.24%), Massachusetts Financial Services Co. MA (2.24%) and Veritas Asset Management LLP (1.91%). Company insiders that own CIGNA stock include Alan Muney, Christopher J Hocevar, David Cordani, Donna F Zarcone, Eric P Palmer, Hoeltzel Mary T Agoglia, Isaiah Harris, Jr, Jane E Md Henney, Jason D Sadler, John M Murabito, Lisa R Bacus, Mary T Hoeltzel, Matthew G Manders, Michael W Triplett, Nicole S Jones, Thomas A Mccarthy and William D Zollars. View Institutional Ownership Trends for CIGNA. Which major investors are selling CIGNA stock? CI stock was sold by a variety of institutional investors in the last quarter, including Dodge & Cox, Swedbank, PointState Capital LP, MERIAN GLOBAL INVESTORS UK Ltd, Levin Capital Strategies L.P., BlackRock Inc., Panagora Asset Management Inc. and Mitsubishi UFJ Trust & Banking Corp. Company insiders that have sold CIGNA company stock in the last year include Alan Muney, Christopher J Hocevar, David Cordani, Donna F Zarcone, Hoeltzel Mary T Agoglia, Isaiah Harris, Jr, Jane E Md Henney, Jason D Sadler, John M Murabito, Michael W Triplett, Nicole S Jones and William D Zollars. View Insider Buying and Selling for CIGNA. Which major investors are buying CIGNA stock? CI stock was bought by a variety of institutional investors in the last quarter, including Capital World Investors, Capital Research Global Investors, Ruffer LLP, FMR LLC, Point72 Asset Management L.P., HealthCor Management L.P., DNB Asset Management AS and Dimensional Fund Advisors LP. View Insider Buying and Selling for CIGNA. How do I buy shares of CIGNA? Shares of CI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is CIGNA's stock price today? One share of CI stock can currently be purchased for approximately $208.14. How big of a company is CIGNA? CIGNA has a market capitalization of $52.05 billion and generates $41.62 billion in revenue each year. The health services provider earns $2.24 billion in net income (profit) each year or $10.46 on an earnings per share basis. CIGNA employs 46,000 workers across the globe. What is CIGNA's official website? The official website for CIGNA is http://www.cigna.com. How can I contact CIGNA? CIGNA's mailing address is 900 COTTAGE GROVE ROAD, BLOOMFIELD CT, 06002. The health services provider can be reached via phone at 860-226-6000 or via email at [email protected] MarketBeat Community Rating for CIGNA (NYSE CI)Community Ranking: 3.0 out of 5 ( )Outperform Votes: 664 (Vote Outperform)Underperform Votes: 450 (Vote Underperform)Total Votes: 1,114MarketBeat's community ratings are surveys of what our community members think about CIGNA and other stocks. Vote "Outperform" if you believe CI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/20/2018 by MarketBeat.com StaffFeatured Article: What is a balanced fund?